FIBROBODIES
Live / Registered — Registered (as of 22 Mar 2022)
What this means for you
Registered since 22 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90133236
- Registration number
- 6674974
- Mark type
- Stylized text
- Filed
- 24 Aug 2020
- Published for opposition
- 24 Aug 2021
- Registered
- 22 Mar 2022
- Attorney of record
- Roberta S. Bren
Goods and services
- Class 001 — Chemicals: Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; Biochemical medicines for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for medical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; carrier excipients consisting of compounds that facilitate delivery of pharmaceutical preparations
- Class 042 — Scientific and technological services: Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, in vitro analysis for medical and pharmaceutical use; Medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the Internet relating to pharmaceutical products
Owner
- LinXis B.V., AMSTERDAM, NL
- LinXis B.V., AMSTERDAM, NL
- LinXis B.V., AMSTERDAM, NL
Prosecution history
- 19 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Aug 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 22 Aug 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Aug 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Aug 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Aug 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Feb 2022 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 18 Jan 2022 — NOTICE OF ALLOWANCE CANCELLED
- 11 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL